ArQule Revenue and Competitors

Claim your profile

Boston, MA USA

Location

$9.5M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • ArQule's total funding is $9.5M.

Employee Data

    00
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.6M4-94%N/AN/A
#2
$2.6M17N/AN/AN/A
#3
$6M39-20%$176.5MN/A
#4
$4.5M29N/AN/AN/A
#5
$2.6M17N/AN/AN/A
#6
N/A145-21%$39.5MN/A
#7
N/A0N/A$9.5MN/A
#8
$15.9M159-39%$135MN/A
#9
$1.7M1157%$20.9MN/A
#10
$2.8M1850%$28.9MN/A

ArQule, Inc. is a drug discovery company that engages in drug discovery programs with partners and for its own account under agreements providing for shared and exclusive commercial rights to chemical compounds with therapeutic potential. The Company's key drug discovery products and programs are Compound Discovery Products, Lead Generation/Optimization Programs and Process Redesign Programs.

keywords:N/A

$9.5M

Total Funding

N/A

Number of Employees

N/A

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

ArQule News

2022-04-20 - Non-Small Cell Lung Cancer Drugs Market Size, Scope And ...

... F. Hoffmann-La Roche Ltd., Eli Lilly and Company, Agennix AG, ArQule Inc., GlaxoSmithKline Pharmaceuticals Limited, Daiichi Sankyo Co.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A0N/A$10.8M
#2
$1614.3M0N/AN/A
#3
$0.1M2N/AN/A
#4
$0.2M2N/AN/A
#5
$0.4M3N/AN/A